The case is being updated.
Pfizer / BioNTech will deliver 50 million extra doses to the EU before July, the EU Commission announced on Wednesday.
Pfizer planned to deliver 200 million doses to the EU during the first half of the year. But now the company will deliver 250 million doses, writes Bloomberg.
This is good news for the union, after the pharmaceutical giant Johnson & Johnson announced on Tuesday that they are stopping the roll-out of the vaccine to investigate blood clot cases.
EU Commission President Ursula von der Leyen said at a press conference on Wednesday afternoon that the extra doses were actually to be delivered at the end of the year, but the delivery has been greatly accelerated, writes Reuters.
She also states that the EU Commission is in talks with Pfizer / BioNTech about new contracts for doses that will be delivered in 2022 and 2023. It is a question of purchasing 1.8 billion doses.
– We must focus on technologies that have shown what they are worth, says von der Leyen.
The EU has already signed two contracts with the companies to deliver 600 million doses this year.
–
